Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic versus Prophylactic Bemiparin in Hospitalized Patients with Nonsevere COVID-19 Pneumonia (BEMICOP Study): An Open-Label, Multicenter, Randomized, Controlled Trial
María Marcos‐Jubilar, Francisco Carmona-Torre, Rosa Vidal, et al.
Thrombosis and Haemostasis (2021) Vol. 122, Iss. 02, pp. 295-299
Open Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: January 2022 update on the use of therapeutic-intensity anticoagulation in acutely ill patients
Adam Cuker, Eric Tseng, Robby Nieuwlaat, et al.
Blood Advances (2022) Vol. 6, Iss. 17, pp. 4915-4923
Open Access | Times Cited: 56
Clinical features of thrombosis and bleeding in COVID-19
Mari R. Thomas, Marie Scully
Blood (2022) Vol. 140, Iss. 3, pp. 184-195
Open Access | Times Cited: 41
Effects of Standard-Dose Prophylactic, High-Dose Prophylactic, and Therapeutic Anticoagulation in Patients With Hypoxemic COVID-19 Pneumonia
Vincent Labbé, Damien Contou, Nicholas Heming, et al.
JAMA Internal Medicine (2023) Vol. 183, Iss. 6, pp. 520-520
Open Access | Times Cited: 21
Appropriate thromboprophylaxis strategy for COVID-19 patients on dosage, antiplatelet therapy, outpatient and post-discharge prophylaxis: a meta-analysis of randomized controlled trials
Jiahao Meng, Hang Tang, Yifan Xiao, et al.
International Journal of Surgery (2024)
Open Access | Times Cited: 8
COVID-19-Associated Pulmonary Embolism: Review of the Pathophysiology, Epidemiology, Prevention, Diagnosis, and Treatment
Luis Ortega‐Paz, Azita H. Talasaz, Parham Sadeghipour, et al.
Seminars in Thrombosis and Hemostasis (2022) Vol. 49, Iss. 08, pp. 816-832
Open Access | Times Cited: 28
Therapeutic Versus Non‐Therapeutic Dose Anticoagulation in COVID‐19 Infection: A Systematic Review and Meta‐analysis of Randomised Controlled Trials
Sushil Selvarajan, Jisha Sara John, Prathap Tharyan, et al.
eJHaem (2025) Vol. 6, Iss. 1
Open Access
Intestinal Damage in COVID-19: SARS-CoV-2 Infection and Intestinal Thrombosis
Xiaoming Wu, Haijiao Jing, Chengyue Wang, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 25
Therapeutic anticoagulation to prevent thrombosis, coagulopathy, and mortality in severe COVID‐19: The Swiss COVID‐HEP randomized clinical trial
Marc Blondon, Sara Cereghetti, Jérôme Pugin, et al.
Research and Practice in Thrombosis and Haemostasis (2022) Vol. 6, Iss. 4, pp. e12712-e12712
Open Access | Times Cited: 25
Thrombosis and Haemostasis 2022 Editors' Choice Papers
Christian Weber, Xavier Blanchet, Gregory Y.H. Lip
Thrombosis and Haemostasis (2023) Vol. 123, Iss. 01, pp. 123-130
Closed Access | Times Cited: 14
Anticoagulant Treatment Regimens in Patients With Covid‐19: A Meta‐Analysis
Anselm Jorda, Jolanta M. Siller‐Matula, Markus Zeitlinger, et al.
Clinical Pharmacology & Therapeutics (2021) Vol. 111, Iss. 3, pp. 614-623
Open Access | Times Cited: 27
Efficacy and safety of heparin full-dose anticoagulation in hospitalized non-critically ill COVID-19 patients: a meta-analysis of multicenter randomized controlled trials
Eros Pilia, Alessandro Belletti, Stefano Fresilli, et al.
Journal of Thrombosis and Thrombolysis (2022) Vol. 54, Iss. 3, pp. 420-430
Open Access | Times Cited: 20
Practical Recommendations for Optimal Thromboprophylaxis in Patients with COVID-19: A Consensus Statement Based on Available Clinical Trials
Konstantinos G. Kyriakoulis, Evangelos Dimakakos, Ioannis Kyriakoulis, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 20, pp. 5997-5997
Open Access | Times Cited: 19
Efficacy and Safety of Tinzaparin in Prophylactic, Intermediate and Therapeutic Doses in Non-Critically Ill Patients Hospitalized with COVID-19: The PROTHROMCOVID Randomized Controlled Trial
Nuria Muñoz‐Rivas, Jesús Aibar, Cristina Gabara-Xancó, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 19, pp. 5632-5632
Open Access | Times Cited: 18
The Effect of Heparin Full-Dose Anticoagulation on Survival of Hospitalized, Non-critically Ill COVID-19 Patients: A Meta-analysis of High Quality Studies
Eros Pilia, Alessandro Belletti, Stefano Fresilli, et al.
Lung (2023) Vol. 201, Iss. 2, pp. 135-147
Open Access | Times Cited: 10
Anticoagulation in COVID-19 patients – An updated systematic review and meta-analysis
Stefanie Reis, Amon Faske, Ina Monsef, et al.
Thrombosis Research (2024) Vol. 238, pp. 141-150
Open Access | Times Cited: 3
Updated meta-analysis of randomized controlled trials on the safety and efficacy of different prophylactic anticoagulation dosing regimens in non-critically ill hospitalized patients with COVID-19
Luis Ortega‐Paz, Mattía Galli, Dominick J. Angiolillo
European Heart Journal - Cardiovascular Pharmacotherapy (2022) Vol. 8, Iss. 3, pp. E15-E17
Open Access | Times Cited: 17
The Role of Heparin in COVID-19: An Update after Two Years of Pandemics
Marco Mangiafico, Andrea Caff, Luca Costanzo
Journal of Clinical Medicine (2022) Vol. 11, Iss. 11, pp. 3099-3099
Open Access | Times Cited: 15
Effect of anticoagulation on the incidence of venous thromboembolism, major bleeding, and mortality among hospitalized COVID-19 patients: an updated meta-analysis
Xinwang Chen, Suyun Zhang, Haiyu Liu, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access | Times Cited: 2
A systematic review of thromboembolic complications and outcomes in hospitalised COVID-19 patients
Hanies Yuhana Othman, Izzati Abdul Halim Zaki, Mohamad Rodi Isa, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
SEOM clinical guidelines on venous thromboembolism (VTE) and cancer (2023)
Laura Ortega, Francisco José Pelegrín Mateo, Rut Porta Balanyà, et al.
Clinical & Translational Oncology (2024) Vol. 26, Iss. 11, pp. 2877-2901
Open Access | Times Cited: 2
High-dose versus low-dose venous thromboprophylaxis in hospitalized patients with COVID-19: a systematic review and meta-analysis
Emanuele Valeriani, Angelo Porfidia, Walter Ageno, et al.
Internal and Emergency Medicine (2022) Vol. 17, Iss. 6, pp. 1817-1825
Open Access | Times Cited: 13
Japanese rapid/living recommendations on drug management for COVID‐19: updated guidelines (July 2022)
Kazuma Yamakawa, Ryo Yamamoto, Takero Terayama, et al.
Acute Medicine & Surgery (2022) Vol. 9, Iss. 1
Open Access | Times Cited: 13
Anticoagulation as secondary prevention of massive lung thromboses in hospitalized patients with COVID-19
Rosaria Sofia, Mattias Carbone, Giovanni Landoni, et al.
European Journal of Internal Medicine (2022) Vol. 100, pp. 21-24
Open Access | Times Cited: 11
COVID-19 Thrombotic Complications and Therapeutic Strategies
Alexander C. Fanaroff, Renato D. Lópes
Annual Review of Medicine (2022) Vol. 74, Iss. 1, pp. 15-30
Open Access | Times Cited: 11
A Literature Review of Pathophysiology, Clinical Manifestations, Medications and Optimal Dosage, Outpatient, and Post-hospitalization Use of Anticoagulation in COVID-19 Patients
Dimitrios Velissaris, Christos Michailides, Iosif Karalis, et al.
The Anatolian Journal of Cardiology (2023), pp. 232-239
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top